104 related articles for article (PubMed ID: 36992575)
1. The effects of patient out-of-pocket costs on insulin use among people with type 1 and type 2 diabetes with Medicare Advantage insurance-2014-2018.
McAdam-Marx C; Ruiz-Negron N; Sullivan JM; Tucker JM
Health Serv Res; 2024 Feb; 59(1):e14152. PubMed ID: 36992575
[TBL] [Abstract][Full Text] [Related]
2. The effects of patient out-of-pocket costs for insulin on medication adherence and health care utilization in patients with commercial insurance; 2007-2018.
McAdam-Marx C; Ruiz-Negron N; Sullivan JM; Tucker JM
J Manag Care Spec Pharm; 2022 May; 28(5):494-506. PubMed ID: 35392659
[No Abstract] [Full Text] [Related]
3. A Multichannel Medication Adherence Intervention Influences Patient and Prescriber Behavior.
Leslie RS; Gilmer T; Natarajan L; Hovell M
J Manag Care Spec Pharm; 2016 May; 22(5):526-38. PubMed ID: 27123914
[TBL] [Abstract][Full Text] [Related]
4. Consequences of forgoing prescription drug subsidies among low-income Medicare beneficiaries with diabetes.
Glynn A; Hernandez I; Roberts ET
Health Serv Res; 2022 Oct; 57(5):1136-1144. PubMed ID: 35430735
[TBL] [Abstract][Full Text] [Related]
5. Physician variation in the de-adoption of ineffective statin and fibrate therapy.
Everhart A; Desai NR; Dowd B; Herrin J; Higuera L; Jeffery MM; Jena AB; Ross JS; Shah ND; Smith LB; Karaca-Mandic P
Health Serv Res; 2021 Oct; 56(5):919-931. PubMed ID: 33569804
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Diabetes Medications Used by Adults With Commercial Insurance vs Medicare Advantage, 2016 to 2019.
McCoy RG; Van Houten HK; Deng Y; Mandic PK; Ross JS; Montori VM; Shah ND
JAMA Netw Open; 2021 Feb; 4(2):e2035792. PubMed ID: 33523188
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial Insurance.
DiStefano MJ; Kang SY; Parasrampuria S; Anderson GF
JAMA Health Forum; 2023 May; 4(5):e231090. PubMed ID: 37234016
[TBL] [Abstract][Full Text] [Related]
8. Low-Cost Generic Program Use by Medicare Beneficiaries: Implications for Medication Exposure Misclassification in Administrative Claims Data.
Pauly NJ; Talbert JC; Brown J
J Manag Care Spec Pharm; 2016 Jun; 22(6):741-51. PubMed ID: 27231801
[TBL] [Abstract][Full Text] [Related]
9. Compared to commercially insured patients, Medicare advantage patients adopt newer diabetes drugs more slowly and adhere to them less.
Flory JH; Li J; Dawwas GK; Leonard CE
Endocrinol Diabetes Metab; 2021 Jul; 4(3):e00245. PubMed ID: 34277970
[TBL] [Abstract][Full Text] [Related]
10. The value of coverage in the medicare advantage insurance market.
Dunn A
J Health Econ; 2010 Dec; 29(6):839-55. PubMed ID: 20851485
[TBL] [Abstract][Full Text] [Related]
11. Risk of Nondherence to Diabetes Medications Among Medicare Advantage Enrollees: Development of a Validated Risk Prediction Tool.
Mhatre SK; Serna O; Sansgiry S; Fleming ML; Essien EJ; Sansgiry SS
J Manag Care Spec Pharm; 2016 Nov; 22(11):1293-1301. PubMed ID: 27783546
[TBL] [Abstract][Full Text] [Related]
12. Association between dispensing channel and medication adherence among medicare beneficiaries taking medications to treat diabetes, high blood pressure, or high blood cholesterol.
Iyengar RN; Balagere DS; Henderson RR; LeFrancois AL; Rabbitt RM; Frazee SG
J Manag Care Spec Pharm; 2014 Aug; 20(8):851-61. PubMed ID: 25062079
[TBL] [Abstract][Full Text] [Related]
13. Impact of Out-of-Pocket Pharmacy Costs on Branded Medication Adherence Among Patients with Type 2 Diabetes.
Bibeau WS; Fu H; Taylor AD; Kwan AY
J Manag Care Spec Pharm; 2016 Nov; 22(11):1338-1347. PubMed ID: 27783549
[TBL] [Abstract][Full Text] [Related]
14. Comparison of statin adherence among beneficiaries in MA-PD plans versus PDPs.
Jung K; McBean AM; Kim JA
J Manag Care Pharm; 2012 Mar; 18(2):106-15. PubMed ID: 22380470
[TBL] [Abstract][Full Text] [Related]
15. Adherence and persistence to prescribed medication therapy among Medicare part D beneficiaries on dialysis: comparisons of benefit type and benefit phase.
Park H; Rascati KL; Lawson KA; Barner JC; Richards KM; Malone DC
J Manag Care Spec Pharm; 2014 Aug; 20(8):862-76. PubMed ID: 25062080
[TBL] [Abstract][Full Text] [Related]
16. The association of adherence to osteoporosis therapies with fracture, all-cause medical costs, and all-cause hospitalizations: a retrospective claims analysis of female health plan enrollees with osteoporosis.
Halpern R; Becker L; Iqbal SU; Kazis LE; Macarios D; Badamgarav E
J Manag Care Pharm; 2011; 17(1):25-39. PubMed ID: 21204588
[TBL] [Abstract][Full Text] [Related]
17. Association of Health Insurance Literacy With Enrollment in Traditional Medicare, Medicare Advantage, and Plan Characteristics Within Medicare Advantage.
Park S; Langellier BA; Meyers DJ
JAMA Netw Open; 2022 Feb; 5(2):e2146792. PubMed ID: 35113164
[TBL] [Abstract][Full Text] [Related]
18. Predictors of adherence to oral anticancer medications: An analysis of 2010-2018 US nationwide claims.
Vyas A; Descoteaux A; Kogut S; Parikh MA; Campbell PJ; Green A; Westrich K
J Manag Care Spec Pharm; 2022 Aug; 28(8):831-844. PubMed ID: 35876294
[No Abstract] [Full Text] [Related]
19. How do Medicare Advantage beneficiary payments vary with tenure?
Jacobs PD; Molloy E
Am J Manag Care; 2017 Jun; 23(6):372-377. PubMed ID: 28817299
[TBL] [Abstract][Full Text] [Related]
20. Prescribing of low- versus high-cost Part B drugs in Medicare Advantage and traditional Medicare.
Anderson KE; Polsky D; Dy S; Sen AP
Health Serv Res; 2022 Jun; 57(3):537-547. PubMed ID: 34806171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
